SlideShare una empresa de Scribd logo
1 de 21
Investor Presentation
      June 2012
Forward Looking Statements


Statements contained in this presentation that are not historical facts are
forward looking statements which involve certain risks and uncertainties
including, but not limited to, risks associated with the uncertainty of managing
rapidly changing technologies, limited access to capital, competition, the ability
to attract and retain qualified employees, our ability to execute our strategy, the
uncertainty of the future performance of our partner companies, acquisitions
and dispositions of additional partner companies, the inability to manage
growth, government regulation and legal liabilities and the effect of economic
conditions in the business sectors in which our partner companies operate,
negative media coverage and other uncertainties as described in our filings
with the Securities and Exchange Commission, including our Annual Report on
Form 10-K.

Safeguard does not assume any obligation to update any forward looking
statements or other information contained in this presentation.



                                                                                      2
The Safeguard Difference (NYSE: SFE)




     SIGNIFICANTLY              UNDERVALUED




                                              3
Why Own Safeguard?


 Full Value Yet to be Realized

 Ownership Stakes in Exciting Partner Companies

 Top Performance of Proven Team

 Financial Strength, Flexibility and Liquidity

 Strong Alignment of Interests




                                                   4
Experienced Team

    Peter J. Boni             Online
                             Software
                                             Prime
                                           Response
                           International
    President and CEO


    Jim Datin

    EVP and
    Managing Director


    Steve Zarrilli

    SVP and CFO


    Brian Sisko

    SVP and
    General Counsel

    John E. Shave III
    VP, Corporate
    Communications and
    Business Development

                                                      5
The Company We Keep



Alliances &
Syndication
Partnerships




Technology &
Life Sciences
Advisory        JA 3 Partners
Boards




SFE Board of
Directors




                                6
Safeguard Today




                  7
Safeguard Positioning




                        8
Go To Market Strategy



 Growth Financing
 Typically Deploy Up to $25M

 Generally Primary Shareholder

 Realize Value




GROWTH DRIVERS       CRITERIA
• Maturity           • Management
• Migration          • Market
• Convergence        • Model
• Compliance         • Momentum
• Cost Containment   • Moat



                                    9
Attractive Sectors




* Represents % of Capital Deployed in Current Partner Companies.   10
Recent Success Stories

                                                                           Cash-on-Cash
             Acquired By                   Proceeds*
                                                                              Return


                                               $36M                                    4x



                                              $138M                                   13x



                                               $36M                                    3x
                                                                          Return Potential Could
                                                                             Approach 8x***



                                            $208M**                                    3x
                                                                         Market Cap Increased 5x
                   * Includes amounts held in escrow as of March 31, 2012 which are deemed likely to be
                   realized during 2012, if any, but not unearned milestones / earnouts, where applicable.
                                      ** Proceeds include $61M from sale of CLRT shares during Q3’09.
                                                  *** Based on achievement of difficult earnout provisions.
                                                                                                              11
Revenue Stages




                 12
Case Study:                       SFE Stake 25%


•   Medical Technology Company
•   Developed and is Commercializing emPower!
•   emPower! Most Significant Change in Eyeglasses Since Bifocal in 1784
•   100M Bifocals and Progressive Lenses Sold Per Year
•   Every 1% Penetration = $400M in Revenue
•   1000+ Eye Care Professionals Signed On
•   SFE Deployed $27.1M since April 2011




                                                                           13
Case Study:                                                               SFE Stake 40%

             •      Top 10 Provider of Medical Billing and Practice Management Services
             •      U.S. Market Opportunity Exceeds $4B Annually
             •      <20% Physician Practices Outsource Billing and Practice Management
             •      Gaining Meaningful Scale via Organic Growth and Strategic Acquisitions
             •      Completed Five Acquisitions since mid-2009
             •      2011 Revenue Increased 40% YoY to ~$40M
             •      Inc.5000 Three Consecutive Years; Ranked #10 Fastest Growing Co. in NJ
             •      SFE Deployed $15.3M since November 2006

                                                                                                                    Market for AHS' Services Approx. $4B - $8B1




1
    Billing and Practice Management Service Market (Falcon Capital): $8.0B; Total RCM Market (Wallingford Capital/HBMA, 2007): $4.75 B; Top 10 Billing cos.: $1.0B   14
Case Study:                    SFE Stake 22%


•   Provides Enterprise-Class Technology and Services to Advertisers/Agencies
•   ‘Bloomberg’ Terminal: Media Buying Platform
•   Named #1 Demand-Side Platform Vendor by Forrester Research
•   Strong Growth Continues
•   Expanding Domestic, International Operations
•   Strong Client Roster – All Agency Groups, Dozens of Fortune 500
•   SFE Deployed $16.9M since July 2009




                                                                                15
Safeguard Partner Companies



                           16 Partner Companies Today
Aggregate Revenue*
                           25 Board Seats Across 16 Companies

                           15 Companies Generating Revenue

                           4 Companies EBITDA Positive

                           1 Company Filed NDA

                           Deployed $177M in Current Partner Companies

                           Realized $635M Since January 2006

                           Strong Partner Company Satisfaction




                           * Aggregate revenue guidance for 2012 and prior years, presented
                             above, reflects revenue on a net basis. Revenue figures utilized for
                             certain companies pertain to periods prior to Safeguard’s
                             involvement with said companies and based solely on information
                             provided to Safeguard by such companies. Safeguard reports the
                             revenue of its equity method and cost method partner companies on
                             a one-quarter lag basis.


                                                                                                16
Financial Highlights


• Net Cash, Cash Equivalents and Marketable Securities
   – $188.5M at 3/31/12 vs. $211.9M at 12/31/11

• Q1’12 Primary Uses of Cash = $25.9M

• 2012 Projected Uses of Cash = $100M to $150M
   – Capital Deployment into New Partner Companies

   – Follow-on Funding for Current Partner Companies and Penn Mezzanine
     Participations

   – Corporate Expenses

   – Platform Expansion



                                                                          17
Strategy for Growth


 Build Value in Current Holdings

 Realize Some Valuable Exits

 Replenish The Holdings with Winners

 Expand the Platform




                                        18
Why Own Safeguard?


 Full Value Yet to be Realized

 Ownership Stakes in Exciting Partner Companies

 Top Performance of Proven Team

 Financial Strength, Flexibility and Liquidity

 Strong Alignment of Interests




                                                   19
The Safeguard Difference (NYSE: SFE)




     SIGNIFICANTLY              UNDERVALUED




                                              20
Investor Presentation
      June 2012

Más contenido relacionado

La actualidad más candente

Ubs investment banking challenge national finals presentation
Ubs investment banking challenge national finals presentation Ubs investment banking challenge national finals presentation
Ubs investment banking challenge national finals presentation
jphil90
 
Icm aniacs report final
Icm aniacs report finalIcm aniacs report final
Icm aniacs report final
George Cotton
 
CloroxAR08_Letter
CloroxAR08_LetterCloroxAR08_Letter
CloroxAR08_Letter
finance48
 
Abittan Lori RS_Final
Abittan Lori RS_FinalAbittan Lori RS_Final
Abittan Lori RS_Final
Lori Abittan
 
Tanger Presentation - Final
Tanger Presentation - FinalTanger Presentation - Final
Tanger Presentation - Final
Carter Chen
 
Pdg Raises Its Stake On Goldfarb To 70%
Pdg Raises Its Stake On Goldfarb To 70%Pdg Raises Its Stake On Goldfarb To 70%
Pdg Raises Its Stake On Goldfarb To 70%
PDG Realty
 
Joint venture and mergers and acquition
Joint venture and mergers and acquitionJoint venture and mergers and acquition
Joint venture and mergers and acquition
Dhanush M Holla
 
1st annual Brazil conference, Nova York, 15 e 16 de Maio de 2006
1st annual Brazil conference, Nova York, 15 e 16 de Maio de 20061st annual Brazil conference, Nova York, 15 e 16 de Maio de 2006
1st annual Brazil conference, Nova York, 15 e 16 de Maio de 2006
Gafisa RI !
 

La actualidad más candente (19)

Taylor Frigon Open House, July 2012
Taylor Frigon Open House, July 2012Taylor Frigon Open House, July 2012
Taylor Frigon Open House, July 2012
 
Taylor Frigon Capital Management Open House, July 2012
Taylor Frigon Capital Management Open House, July 2012Taylor Frigon Capital Management Open House, July 2012
Taylor Frigon Capital Management Open House, July 2012
 
Ubs investment banking challenge national finals presentation
Ubs investment banking challenge national finals presentation Ubs investment banking challenge national finals presentation
Ubs investment banking challenge national finals presentation
 
Icm aniacs report final
Icm aniacs report finalIcm aniacs report final
Icm aniacs report final
 
CloroxAR08_Letter
CloroxAR08_LetterCloroxAR08_Letter
CloroxAR08_Letter
 
Multiplus Investor Presentation - BTG Conferene
Multiplus Investor Presentation - BTG ConfereneMultiplus Investor Presentation - BTG Conferene
Multiplus Investor Presentation - BTG Conferene
 
Valuation of merger & acquasition in india
Valuation of merger & acquasition in indiaValuation of merger & acquasition in india
Valuation of merger & acquasition in india
 
Taylor frigon open house slides 07 2012
Taylor frigon open house slides 07 2012Taylor frigon open house slides 07 2012
Taylor frigon open house slides 07 2012
 
Mercer Capital | Valuation Insight | Corporate Finance in 30 Minutes
Mercer Capital | Valuation Insight | Corporate Finance in 30 Minutes Mercer Capital | Valuation Insight | Corporate Finance in 30 Minutes
Mercer Capital | Valuation Insight | Corporate Finance in 30 Minutes
 
Financial Times - Hedge fund survey top five funds
Financial Times - Hedge fund survey top five fundsFinancial Times - Hedge fund survey top five funds
Financial Times - Hedge fund survey top five funds
 
Abittan Lori RS_Final
Abittan Lori RS_FinalAbittan Lori RS_Final
Abittan Lori RS_Final
 
Mercer Capital's Asset Management Industry Newsletter | Q3 2012 | Focus: Alte...
Mercer Capital's Asset Management Industry Newsletter | Q3 2012 | Focus: Alte...Mercer Capital's Asset Management Industry Newsletter | Q3 2012 | Focus: Alte...
Mercer Capital's Asset Management Industry Newsletter | Q3 2012 | Focus: Alte...
 
Ocfn small cap growth strategy q 1 2013 overview wie
Ocfn small cap growth strategy q 1 2013 overview wieOcfn small cap growth strategy q 1 2013 overview wie
Ocfn small cap growth strategy q 1 2013 overview wie
 
Tanger Presentation - Final
Tanger Presentation - FinalTanger Presentation - Final
Tanger Presentation - Final
 
Pdg Raises Its Stake On Goldfarb To 70%
Pdg Raises Its Stake On Goldfarb To 70%Pdg Raises Its Stake On Goldfarb To 70%
Pdg Raises Its Stake On Goldfarb To 70%
 
Joint venture and mergers and acquition
Joint venture and mergers and acquitionJoint venture and mergers and acquition
Joint venture and mergers and acquition
 
1st annual Brazil conference, Nova York, 15 e 16 de Maio de 2006
1st annual Brazil conference, Nova York, 15 e 16 de Maio de 20061st annual Brazil conference, Nova York, 15 e 16 de Maio de 2006
1st annual Brazil conference, Nova York, 15 e 16 de Maio de 2006
 
theories merger
 theories merger theories merger
theories merger
 
Ch01
Ch01Ch01
Ch01
 

Similar a Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012

Safeguard Scientifics (NYSE:SFE) Corporate Presentation - March 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - March 2014Safeguard Scientifics (NYSE:SFE) Corporate Presentation - March 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - March 2014
Safeguard Scientifics
 
Coca Cola 2013 CAGNY Presentation
Coca Cola 2013 CAGNY PresentationCoca Cola 2013 CAGNY Presentation
Coca Cola 2013 CAGNY Presentation
Neil Kimberley
 
PRO_CaseStudy_Aspiriant
PRO_CaseStudy_AspiriantPRO_CaseStudy_Aspiriant
PRO_CaseStudy_Aspiriant
Joseph Clark
 

Similar a Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012 (20)

Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...
 
Synergy
Synergy   Synergy
Synergy
 
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - March 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - March 2014Safeguard Scientifics (NYSE:SFE) Corporate Presentation - March 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - March 2014
 
Safeguard Scientifics Third Quarter 2012 Financial Results Presentation
Safeguard Scientifics Third Quarter 2012 Financial Results PresentationSafeguard Scientifics Third Quarter 2012 Financial Results Presentation
Safeguard Scientifics Third Quarter 2012 Financial Results Presentation
 
Des Moines Insurance Conference 2016
Des Moines Insurance Conference 2016Des Moines Insurance Conference 2016
Des Moines Insurance Conference 2016
 
Coca Cola 2013 CAGNY Presentation
Coca Cola 2013 CAGNY PresentationCoca Cola 2013 CAGNY Presentation
Coca Cola 2013 CAGNY Presentation
 
Investor Presentation September 2014
Investor Presentation September 2014 Investor Presentation September 2014
Investor Presentation September 2014
 
Investor deck 19205
Investor deck 19205Investor deck 19205
Investor deck 19205
 
PRO_CaseStudy_Aspiriant
PRO_CaseStudy_AspiriantPRO_CaseStudy_Aspiriant
PRO_CaseStudy_Aspiriant
 
Kernan-PPT-11-29-12-1
Kernan-PPT-11-29-12-1Kernan-PPT-11-29-12-1
Kernan-PPT-11-29-12-1
 
Moelis Company July Investor Presentation
Moelis Company July Investor PresentationMoelis Company July Investor Presentation
Moelis Company July Investor Presentation
 
Moelis Company - Q3 Investor Presentation
Moelis Company - Q3 Investor PresentationMoelis Company - Q3 Investor Presentation
Moelis Company - Q3 Investor Presentation
 
Presentation aux investisseurs (anglais seulement) mai 2013
Presentation aux investisseurs (anglais seulement) mai 2013Presentation aux investisseurs (anglais seulement) mai 2013
Presentation aux investisseurs (anglais seulement) mai 2013
 
Investor Presentation May 2013
Investor Presentation May 2013Investor Presentation May 2013
Investor Presentation May 2013
 

Más de Safeguard Scientifics

Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
Safeguard Scientifics
 
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - December 2013
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - December 2013Safeguard Scientifics (NYSE:SFE) Corporate Presentation - December 2013
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - December 2013
Safeguard Scientifics
 
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - November 2013
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - November 2013Safeguard Scientifics (NYSE:SFE) Corporate Presentation - November 2013
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - November 2013
Safeguard Scientifics
 
10.25.12 sfe q3 2012 results presentation final
10.25.12 sfe q3 2012 results   presentation final10.25.12 sfe q3 2012 results   presentation final
10.25.12 sfe q3 2012 results presentation final
Safeguard Scientifics
 

Más de Safeguard Scientifics (16)

Safeguard Scientifics Corporate Presentation - July 2015
Safeguard Scientifics Corporate Presentation - July 2015Safeguard Scientifics Corporate Presentation - July 2015
Safeguard Scientifics Corporate Presentation - July 2015
 
Safeguard Scientifics Corporate Presentation - June 2015
Safeguard Scientifics Corporate Presentation - June 2015Safeguard Scientifics Corporate Presentation - June 2015
Safeguard Scientifics Corporate Presentation - June 2015
 
Safeguard Scientifics Corporate Presentation - May 2015
Safeguard Scientifics Corporate Presentation - May 2015Safeguard Scientifics Corporate Presentation - May 2015
Safeguard Scientifics Corporate Presentation - May 2015
 
Safeguard Scientifics Corporate Presentation - April 24, 2015
Safeguard Scientifics Corporate Presentation - April 24, 2015Safeguard Scientifics Corporate Presentation - April 24, 2015
Safeguard Scientifics Corporate Presentation - April 24, 2015
 
Safeguard Scientifics Corporate Presentation - April 2015
Safeguard Scientifics Corporate Presentation - April 2015Safeguard Scientifics Corporate Presentation - April 2015
Safeguard Scientifics Corporate Presentation - April 2015
 
Safeguard Scientifics Corporate Presentation - March 2015
Safeguard Scientifics Corporate Presentation - March 2015Safeguard Scientifics Corporate Presentation - March 2015
Safeguard Scientifics Corporate Presentation - March 2015
 
Safeguard Scientifics Corporate Presentation - January 2015
Safeguard Scientifics Corporate Presentation - January 2015Safeguard Scientifics Corporate Presentation - January 2015
Safeguard Scientifics Corporate Presentation - January 2015
 
Corporate Presentation - December 2014
Corporate Presentation - December 2014Corporate Presentation - December 2014
Corporate Presentation - December 2014
 
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
 
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - December 2013
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - December 2013Safeguard Scientifics (NYSE:SFE) Corporate Presentation - December 2013
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - December 2013
 
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - November 2013
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - November 2013Safeguard Scientifics (NYSE:SFE) Corporate Presentation - November 2013
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - November 2013
 
10.25.12 sfe q3 2012 results presentation final
10.25.12 sfe q3 2012 results   presentation final10.25.12 sfe q3 2012 results   presentation final
10.25.12 sfe q3 2012 results presentation final
 
Anatomy of a Deal: Avid Radiopharmaceuticals
Anatomy of a Deal: Avid RadiopharmaceuticalsAnatomy of a Deal: Avid Radiopharmaceuticals
Anatomy of a Deal: Avid Radiopharmaceuticals
 
Safeguard Scientifics Second Quarter 2012 Financial Results Presentation
Safeguard Scientifics Second Quarter 2012 Financial Results PresentationSafeguard Scientifics Second Quarter 2012 Financial Results Presentation
Safeguard Scientifics Second Quarter 2012 Financial Results Presentation
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012
 
Safeguard Scientifics Q4 and FY'11 Results Presentation
Safeguard Scientifics Q4 and FY'11 Results PresentationSafeguard Scientifics Q4 and FY'11 Results Presentation
Safeguard Scientifics Q4 and FY'11 Results Presentation
 

Último

From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...
From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...
From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...
From Luxury Escort : 9352852248 Make on-demand Arrangements Near yOU
 
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
dipikadinghjn ( Why You Choose Us? ) Escorts
 
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
dipikadinghjn ( Why You Choose Us? ) Escorts
 
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
dipikadinghjn ( Why You Choose Us? ) Escorts
 

Último (20)

03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx
 
(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7
(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7
(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7
 
The Economic History of the U.S. Lecture 22.pdf
The Economic History of the U.S. Lecture 22.pdfThe Economic History of the U.S. Lecture 22.pdf
The Economic History of the U.S. Lecture 22.pdf
 
(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7
(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7
(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7
 
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
 
The Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfThe Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdf
 
Gurley shaw Theory of Monetary Economics.
Gurley shaw Theory of Monetary Economics.Gurley shaw Theory of Monetary Economics.
Gurley shaw Theory of Monetary Economics.
 
The Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdfThe Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdf
 
From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...
From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...
From Luxury Escort Service Kamathipura : 9352852248 Make on-demand Arrangemen...
 
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
 
Call Girls Koregaon Park Call Me 7737669865 Budget Friendly No Advance Booking
Call Girls Koregaon Park Call Me 7737669865 Budget Friendly No Advance BookingCall Girls Koregaon Park Call Me 7737669865 Budget Friendly No Advance Booking
Call Girls Koregaon Park Call Me 7737669865 Budget Friendly No Advance Booking
 
Stock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfStock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdf
 
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
 
Booking open Available Pune Call Girls Wadgaon Sheri 6297143586 Call Hot Ind...
Booking open Available Pune Call Girls Wadgaon Sheri  6297143586 Call Hot Ind...Booking open Available Pune Call Girls Wadgaon Sheri  6297143586 Call Hot Ind...
Booking open Available Pune Call Girls Wadgaon Sheri 6297143586 Call Hot Ind...
 
Indore Real Estate Market Trends Report.pdf
Indore Real Estate Market Trends Report.pdfIndore Real Estate Market Trends Report.pdf
Indore Real Estate Market Trends Report.pdf
 
The Economic History of the U.S. Lecture 25.pdf
The Economic History of the U.S. Lecture 25.pdfThe Economic History of the U.S. Lecture 25.pdf
The Economic History of the U.S. Lecture 25.pdf
 
Top Rated Pune Call Girls Sinhagad Road ⟟ 6297143586 ⟟ Call Me For Genuine S...
Top Rated  Pune Call Girls Sinhagad Road ⟟ 6297143586 ⟟ Call Me For Genuine S...Top Rated  Pune Call Girls Sinhagad Road ⟟ 6297143586 ⟟ Call Me For Genuine S...
Top Rated Pune Call Girls Sinhagad Road ⟟ 6297143586 ⟟ Call Me For Genuine S...
 
Shrambal_Distributors_Newsletter_Apr-2024 (1).pdf
Shrambal_Distributors_Newsletter_Apr-2024 (1).pdfShrambal_Distributors_Newsletter_Apr-2024 (1).pdf
Shrambal_Distributors_Newsletter_Apr-2024 (1).pdf
 
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
 
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
 

Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012

  • 2. Forward Looking Statements Statements contained in this presentation that are not historical facts are forward looking statements which involve certain risks and uncertainties including, but not limited to, risks associated with the uncertainty of managing rapidly changing technologies, limited access to capital, competition, the ability to attract and retain qualified employees, our ability to execute our strategy, the uncertainty of the future performance of our partner companies, acquisitions and dispositions of additional partner companies, the inability to manage growth, government regulation and legal liabilities and the effect of economic conditions in the business sectors in which our partner companies operate, negative media coverage and other uncertainties as described in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K. Safeguard does not assume any obligation to update any forward looking statements or other information contained in this presentation. 2
  • 3. The Safeguard Difference (NYSE: SFE) SIGNIFICANTLY UNDERVALUED 3
  • 4. Why Own Safeguard?  Full Value Yet to be Realized  Ownership Stakes in Exciting Partner Companies  Top Performance of Proven Team  Financial Strength, Flexibility and Liquidity  Strong Alignment of Interests 4
  • 5. Experienced Team Peter J. Boni Online Software Prime Response International President and CEO Jim Datin EVP and Managing Director Steve Zarrilli SVP and CFO Brian Sisko SVP and General Counsel John E. Shave III VP, Corporate Communications and Business Development 5
  • 6. The Company We Keep Alliances & Syndication Partnerships Technology & Life Sciences Advisory JA 3 Partners Boards SFE Board of Directors 6
  • 9. Go To Market Strategy  Growth Financing  Typically Deploy Up to $25M  Generally Primary Shareholder  Realize Value GROWTH DRIVERS CRITERIA • Maturity • Management • Migration • Market • Convergence • Model • Compliance • Momentum • Cost Containment • Moat 9
  • 10. Attractive Sectors * Represents % of Capital Deployed in Current Partner Companies. 10
  • 11. Recent Success Stories Cash-on-Cash Acquired By Proceeds* Return $36M 4x $138M 13x $36M 3x Return Potential Could Approach 8x*** $208M** 3x Market Cap Increased 5x * Includes amounts held in escrow as of March 31, 2012 which are deemed likely to be realized during 2012, if any, but not unearned milestones / earnouts, where applicable. ** Proceeds include $61M from sale of CLRT shares during Q3’09. *** Based on achievement of difficult earnout provisions. 11
  • 13. Case Study: SFE Stake 25% • Medical Technology Company • Developed and is Commercializing emPower! • emPower! Most Significant Change in Eyeglasses Since Bifocal in 1784 • 100M Bifocals and Progressive Lenses Sold Per Year • Every 1% Penetration = $400M in Revenue • 1000+ Eye Care Professionals Signed On • SFE Deployed $27.1M since April 2011 13
  • 14. Case Study: SFE Stake 40% • Top 10 Provider of Medical Billing and Practice Management Services • U.S. Market Opportunity Exceeds $4B Annually • <20% Physician Practices Outsource Billing and Practice Management • Gaining Meaningful Scale via Organic Growth and Strategic Acquisitions • Completed Five Acquisitions since mid-2009 • 2011 Revenue Increased 40% YoY to ~$40M • Inc.5000 Three Consecutive Years; Ranked #10 Fastest Growing Co. in NJ • SFE Deployed $15.3M since November 2006 Market for AHS' Services Approx. $4B - $8B1 1 Billing and Practice Management Service Market (Falcon Capital): $8.0B; Total RCM Market (Wallingford Capital/HBMA, 2007): $4.75 B; Top 10 Billing cos.: $1.0B 14
  • 15. Case Study: SFE Stake 22% • Provides Enterprise-Class Technology and Services to Advertisers/Agencies • ‘Bloomberg’ Terminal: Media Buying Platform • Named #1 Demand-Side Platform Vendor by Forrester Research • Strong Growth Continues • Expanding Domestic, International Operations • Strong Client Roster – All Agency Groups, Dozens of Fortune 500 • SFE Deployed $16.9M since July 2009 15
  • 16. Safeguard Partner Companies  16 Partner Companies Today Aggregate Revenue*  25 Board Seats Across 16 Companies  15 Companies Generating Revenue  4 Companies EBITDA Positive  1 Company Filed NDA  Deployed $177M in Current Partner Companies  Realized $635M Since January 2006  Strong Partner Company Satisfaction * Aggregate revenue guidance for 2012 and prior years, presented above, reflects revenue on a net basis. Revenue figures utilized for certain companies pertain to periods prior to Safeguard’s involvement with said companies and based solely on information provided to Safeguard by such companies. Safeguard reports the revenue of its equity method and cost method partner companies on a one-quarter lag basis. 16
  • 17. Financial Highlights • Net Cash, Cash Equivalents and Marketable Securities – $188.5M at 3/31/12 vs. $211.9M at 12/31/11 • Q1’12 Primary Uses of Cash = $25.9M • 2012 Projected Uses of Cash = $100M to $150M – Capital Deployment into New Partner Companies – Follow-on Funding for Current Partner Companies and Penn Mezzanine Participations – Corporate Expenses – Platform Expansion 17
  • 18. Strategy for Growth  Build Value in Current Holdings  Realize Some Valuable Exits  Replenish The Holdings with Winners  Expand the Platform 18
  • 19. Why Own Safeguard?  Full Value Yet to be Realized  Ownership Stakes in Exciting Partner Companies  Top Performance of Proven Team  Financial Strength, Flexibility and Liquidity  Strong Alignment of Interests 19
  • 20. The Safeguard Difference (NYSE: SFE) SIGNIFICANTLY UNDERVALUED 20